期刊文献+

CpG ODN对树突状细胞抗肝癌作用的影响 被引量:2

Effects of CpG ODN on dendritic cells in anti-hepatocarcinoma action
下载PDF
导出
摘要 目的 :研究CpGODN在BALB/C小鼠骨髓来源树突状细胞 (BMDC)抗肝癌免疫中的作用。方法 :CpGODN联合肿瘤抗原 (TAg)体外刺激BMDC ,流式细胞术检测受刺激BMDC表达CD80的阳性率 ,ELISA检测受刺激BMDC分泌IL - 12 (p70 )的水平 ,MTT法检测活化BMDC刺激T细胞的增殖能力 ,联合CpGODN和TAg体内预激小鼠获得CTL ,检测CTL对肝癌细胞株Hca-F的特异性杀伤作用。结果 :CpGODN联合TAg体外可明显激活BMDC ,诱导BMDC膜表面CD80的表达 ,刺激BMDC分泌高水平IL - 12 ,促进BMDC刺激T淋巴细胞增殖 ;体内联合应用CpGODN和TAg诱导的CTL对Hca -F具有强大的特异性杀伤作用 ,其诱导作用明显强于TAg ,与细菌脂多糖和金黄色葡萄球菌肠毒素B相近。结论 :CpGODN体外能有效促进小鼠BMDC的分化、增殖和成熟 。 AIM: To study the effect of oligonucleotides containing unmethylated CpG motif (CpG ODN) on mouse bone marrow-derived dendritic cells (BMDCs) in anti-HcaF cytotoxicity. METHODS: BMDCs were stimulated by CpG ODN in combination with tumor antigen (TAg). The expression of CD80 on BMDC surface was analyzed by FCAS. Level of IL-12 (p70) in supernatants of BMDC culture was detected by ELISA. The proliferation of T cells was examined by MTT assay. Cytotoxicity of CTL induced by CpG ODN combining with TAg was detected by MTT assay. RESULTS: CpG ODN combining or not combining with TAg up-regulated the expression of CD80 on BMDC surface and stimulated BMDCs to produce a high level of IL-12. CpG ODN-activated BMDC promoted the proliferation of T cells. CTL induced by CpG ODN in combination with TAg appeared strong specific cytotoxicity on Hca-F cells. CONCLUSION: CpG ODN may effectively induce the functional maturation of mouse BMDC in vitro. CpG ODN in combination with TAg can enhance the anti-HcaF cytotoxicity of CTL. [
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第10期1801-1805,共5页 Chinese Journal of Pathophysiology
关键词 胞嘧啶鸟嘌呤二核苷酸 寡二核苷类 树突状细胞 T淋巴细胞 细胞毒性 Cytosine-phosphate-guanine Oligonucleotides Dendritic cells T-lymphocytes, cytotoxic
  • 相关文献

参考文献13

  • 1Restifo NP. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape[J]. Nat Med, 2000, 6(5):493-495.
  • 2Krieg AM, Yi AK, Klinman DM, et al. CpG motifs in bacterial DNA trigger direct B-cell activation[J]. Nature, 1995, 374(6522):546-549.
  • 3Condon C, Watkins SC, Celluzzi CM, et al. DNA-based immunization by in vivo transfection of dendritic cells[J]. Nat Med, 1996, 2(10):1122-1128.
  • 4Pichyangkul S, Yongvanitchit K, Kum-arb U, et al. Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides[J]. J Immunol Methods, 2001, 247(1-2):83-94.
  • 5Livingstone AM, Kuhn M. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens[J]. Eur J Immunol, 1999, 29(9):2826-2834.
  • 6Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow[J]. J Immunol Methods, 1999, 223(1):77-92.
  • 7Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells[J]. Annu Rev Immunol,2000, 18(1):767-811.
  • 8Liptom A. Bisphosphonates and breast carcinoma: present and future[J]. Cancer, 2000, 88(12 Suppl):3033-3037.
  • 9Behboudi S, Chao D, Klenerman P, et al. The effects of DNA containing CpG motif on dendritic cells[J]. Immunology, 2000, 99(3):361-366.
  • 10Kelleher M, Beverley PC. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential[J]. J Immunol, 2001, 167(11):6247-6255.

二级参考文献14

  • 1Tahara K, Mori M, Sadanaga N, et al. Expression of the MAGE gene family in human hepatocelar carcinoma[J]. Cancer, 1999, 85(6): 1234-1240.
  • 2Chen CH, Huang GT, Lee HS, et al. High frequency of expression of MAGE genes in human hepatocellular carcinoma[J]. Liver, 1999,19(2):110-114.
  • 3Melief CJ, Toes RE, Medema JP, et al. Strategies for immunotherapy of cancer[J]. Adv Immunol, 2000,75: 235-282.
  • 4Chaux P, Vantomme V, Stroobant V, et al. Identification of MAGE- 3 epitopes presented by HLA- DR molecules to CD4^+ T lymphocytes[Jl. J Exp Med, 1999,189(5): 767-777.
  • 5Manici S, Stumiolo T, Imro MA, et al. Melanoma cells present a MAGE- 3 epitope to CD4^+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11[J]. J Exp Med, 1999, 189(5): 871- 876.
  • 6Miconnet I, Servis C, Cerottini JC, et al. Amino acid identity and/or position determines the proteasomal cleavage of the HLA- A 0201 -restricted peptide tumor antigen MAGE- 3 271 - 279[J]. J Bio Chem, 2000,275(35) : 26892- 26897.
  • 7Eifuku R, Takenoyama M, Yoshino I, et al. Analysis of MAGE- 3 drived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes[J]. Int J Clin Oncol, 2001,6(1): 34-39.
  • 8Schuler G, Steinmam RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors[J]. J Exp Med, 1997,186(8): 1183- 1187.
  • 9Toungouz M, Lambermont M, Velu T, et al. Anti- tumor immunotherapy based on dendritic cells [ J ]. J Soc Biol,2001,195(1): 19-23.
  • 10Chapuis F, Bosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro[J]. Eur J Immunol, 1997,27(2): 431-434.

共引文献13

同被引文献17

  • 1李东升,王军,李家文,刘志香.寻常性银屑病患者皮损中抗菌肽LL-37和人β防御素-2mRNA的表达[J].临床皮肤科杂志,2005,34(6):356-358. 被引量:4
  • 2LAUBE D M,YIM S,RYAN L K,et al.Antimicrobial peptides in the airway[J].Curr Top Microbiol Immunol,2006,306:153-182.
  • 3MUTWIRI G,VAN DRUNEN LITTEL-VAN DEN HURK S,BABIUK L A.Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides[J].Adv Drug Deliv Rev,2009,61(3):226-232.
  • 4VERTHELYI D,KLINMAN D M.Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates[J].Clin Immunol,2003,109 (1):64-71.
  • 5TOKUNAGA T,YAMAMOTO H,SHIMADA S,et al.Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG I Isolation,physicochemical characterization,and antitumor activity[J].J Natl Cancer Inst,1984,72(4):955-962.
  • 6KRIEG A M,YI A K,KLINMAN D M,et al.CpG motifs in bacterial DNA trigger direct B-cell activation[J].Nature,1995,374 (6522):546-549.
  • 7ALBANESI C,FAIRCHILD H R,MADONNA S,et al.IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through STAT-6,suppressor of cytokine signaling (SOCS)-1,and SOCS-3[J].J Immunol,2007,179(2):984-992.
  • 8GHOSH S K,GERKEN T A,SCHNEIDER K M,et al.Quantification of human beta-defensin-2 and-3 in body fluids:application for studies of innate immunity[J].Clin Chem,2007,53(4):757-765.
  • 9JANG B C,LIM K J,SUH M H,et al.Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression:involvement of p38 MAPK,JNK,MKP-1,and NF-kappaB transcriptional factor in A549 cells[J].FEMS Immunol Med Microbiol,2007,51(1):171-184.).
  • 10Diamond G, Beckloff N, Weinberg A, et al. The roles of antimicrobial peptides in innate host defense [J]. Curr Pharm Des, 2009,15 (21 ) : 2377-2392.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部